117 related articles for article (PubMed ID: 10348189)
1. Determination of concentrations of flecainide in human serum by high-performance liquid chromatography on a fluorocarbon-bonded silica gel column.
Obayashi M; Kosugi T; Yamazaki J; Matsumoto Y; Fukuoka M; Matsumoto M
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):219-23. PubMed ID: 10348189
[TBL] [Abstract][Full Text] [Related]
2. High performance liquid chromatography for routine monitoring of serum flecainide.
Nakagawa R; Homma M; Kuga K; Yamaguchi I; Kobayashi D; Morimoto Y; Kohda Y
J Pharm Biomed Anal; 2002 Aug; 30(1):171-4. PubMed ID: 12151077
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of flecainide in serum using high-performance liquid chromatography and electrospray mass spectrometry.
Breindahl T
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):249-54. PubMed ID: 11076078
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography.
Doki K; Homma M; Kuga K; Watanabe S; Yamaguchi I; Kohda Y
J Pharm Biomed Anal; 2004 Sep; 35(5):1307-12. PubMed ID: 15336377
[TBL] [Abstract][Full Text] [Related]
5. Application of a bonded-phase extraction column for rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis--fluorescence or ultraviolet detection.
Chang SF; Miller AM; Fox JM; Welscher TM
Ther Drug Monit; 1984; 6(1):105-11. PubMed ID: 6710553
[TBL] [Abstract][Full Text] [Related]
6. Improved solid-phase extraction technique for plasma flecainide analysis by high-performance liquid chromatography.
Wilson KM; Schneider JJ; Ravenscroft PJ
Ther Drug Monit; 1998 Aug; 20(4):435-8. PubMed ID: 9712470
[TBL] [Abstract][Full Text] [Related]
7. Measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detection.
Plomp TA; Boom HT; Maes RA
J Anal Toxicol; 1986; 10(3):102-6. PubMed ID: 3724068
[TBL] [Abstract][Full Text] [Related]
8. Validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of flecainide in human plasma and its clinical application.
Mano Y; Asakawa Y; Kita K; Ishii T; Hotta K; Kusano K
Biomed Chromatogr; 2015 Sep; 29(9):1399-405. PubMed ID: 25641720
[TBL] [Abstract][Full Text] [Related]
9. Assay of flecainide in serum by high-performance liquid chromatography after microscale protein precipitation.
Malikin G; Murphy M; Lam S
Ther Drug Monit; 1989; 11(2):210-3. PubMed ID: 2497564
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detection.
Turgeon J; Kroemer HK; Prakash C; Blair IA; Roden DM
J Pharm Sci; 1990 Feb; 79(2):91-5. PubMed ID: 2109058
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic method for the quantitation of flecainide, a new antiarrhythmic, in human plasma and urine.
Chang SF; Welscher TM; Miller AM; Ober RE
J Chromatogr; 1983 Feb; 272(2):341-50. PubMed ID: 6833431
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective analysis of flecainide enantiomers using reversed-phase liquid chromatography for assessing CYP2D6 activity.
Doki K; Sekiguchi Y; Kuga K; Aonuma K; Kohda Y; Homma M
Biomed Chromatogr; 2014 Sep; 28(9):1193-8. PubMed ID: 24523024
[TBL] [Abstract][Full Text] [Related]
13. Concurrent measurement of flecainide acetate and propranolol by normal-phase high-performance liquid chromatography.
Rognerud CL; Ou CN
Clin Chem; 1989 May; 35(5):857-60. PubMed ID: 2498017
[TBL] [Abstract][Full Text] [Related]
14. Determination of captopril in human serum by high performance liquid chromatography using solid-phase extraction.
Bahmaei M; Khosravi A; Zamiri C; Massoumi A; Mahmoudian M
J Pharm Biomed Anal; 1997 May; 15(8):1181-6. PubMed ID: 9215971
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum.
Straka RJ; Hoon TJ; Lalonde RL; Pieper JA; Bottorff MB
Clin Chem; 1987 Oct; 33(10):1898-900. PubMed ID: 3117433
[TBL] [Abstract][Full Text] [Related]
16. A high performance liquid chromatographic method for the quantitation of flecainide in plasma.
Broly F; Marecaux P; Houdret N; Lhermitte M; Houssin R
Biomed Chromatogr; 1991 Nov; 5(6):248-50. PubMed ID: 1760591
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic determination of the enantiomers of flecainide in human plasma and urine.
Alessi-Severini S; Jamali F; Pasutto FM; Coutts RT; Gulamhusein S
J Pharm Sci; 1990 Mar; 79(3):257-60. PubMed ID: 2110973
[TBL] [Abstract][Full Text] [Related]
18. Stability-indicating chromatographic methods for determination of flecainide acetate in the presence of its degradation products; isolation and identification of two of its impurities.
El-Ragehy NA; Hassan NY; Tantawy MA; Abdelkawy M
Biomed Chromatogr; 2016 Oct; 30(10):1541-8. PubMed ID: 26992079
[TBL] [Abstract][Full Text] [Related]
19. [Determination of the concentration of a new antiarrhythmic, flecainide, in plasma using high pressure liquid chromatography (HPLC): sample preparation with extraction columns].
Becker JU
J Clin Chem Clin Biochem; 1984 May; 22(5):389-93. PubMed ID: 6470629
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection.
Malavasi B; Ripamonti M; Rouchouse A; Ascalone V
J Chromatogr A; 1996 Apr; 729(1-2):323-33. PubMed ID: 9004957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
